Detalles de la búsqueda
1.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol;
12(4): 493-502, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26776493
2.
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
BJU Int;
115(5): 764-71, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24988879
3.
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.
Future Oncol;
11(21): 2881-91, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26436290
4.
Primary thromboprophylaxis in not surgically treated intra-luminal gastrointestinal cancer (ILGC) treated with first-line chemotherapy: A single institution preliminary safety report.
SAGE Open Med Case Rep;
11: 2050313X231158483, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36896327
5.
Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series study.
J Oncol Pharm Pract;
18(1): 10-6, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21228085
6.
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Eur J Cancer;
155: 56-63, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358777
7.
Adipose-Derived Stem Cell Treatments and Formulations.
Clin Sports Med;
38(1): 61-78, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30466723
8.
Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancer.
Oncol Lett;
11(1): 3-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26870160
9.
Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme.
Clin Genitourin Cancer;
14(1): 48-55, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26382222
10.
Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger.
Urol Oncol;
33(6): 265.e15-21, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25907622
11.
Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.
Eur Urol;
68(1): 147-53, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25457020
12.
Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapies.
Onco Targets Ther;
7: 1115-21, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24971022
13.
Early detection, prevention and management of cutaneous adverse events due to sorafenib: recommendations from the Sorafenib Working Group.
Crit Rev Oncol Hematol;
82(3): 378-86, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21944842
14.
[Evolution of the parameters indicating response to drug therapy: from regression to complete control of the disease and the symptoms]. / Evoluzione dei parametri di risposta ai farmaci: dalla regressione al controllo complessivo della malattia e dei sintomi.
Tumori;
88(6): A7-9, 2002.
Artículo
en Italiano
| MEDLINE | ID: mdl-12597158
15.
[Antiblastic therapy and anticoagulation: a new frontier?]. / Terapia antiblastica e anticoagulazione una nuova frontiera?
Suppl Tumori;
3(2): S33-5, 2004.
Artículo
en Italiano
| MEDLINE | ID: mdl-15067963
16.
[Rational and results of a scheduled sequential combination in advanced non-small cell lung carcinoma]. / Razionale e risultati delle schedule di combinazione sequenziale nel carcinoma polmonare non microcitoma avanzato.
Suppl Tumori;
3(2): S38-41, 2004.
Artículo
en Italiano
| MEDLINE | ID: mdl-15067965
Resultados
1 -
16
de 16
1
Próxima >
>>